Health X Platform Limited
NSE: HEALTHX · Healthcare Service Provider · sector
₹269.50NSE close 2026-10-26
Key numbers
Market cap₹857 cr
Price₹269.50
52w high / low₹348 / ₹267
P/E–Sector median 22.9x
P/B3.2xSector median 2.0x
Book value₹85.2
Dividend yield–Sector median 0.55%
ROE-0.5%Sector median 5.4%
ROA-0.50%Sector median 3.26%
Gross NPA–
Net NPA–
CET1–
Sales growth 3y–Sector median +13.5%
Profit growth 3y–Sector median +26.9%
PEG–
Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- No promoter shares are pledged.
- Net loss in 8 of the last 8 quarters.
- Total income was higher than a year earlier in 0 of the last 4 quarters.
- No dividend in the last 5 financial years.
- Price ₹269.50 on 2026-10-26: -22.5% from the 52-week high, +0.9% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹377.25 · low ₹210.86
Total incomeNet profit
Total incomeNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Total income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 |
| EPS (₹) | -0.10 | -0.03 | -0.02 | -0.03 | -0.09 | -0.13 | -0.05 | -0.16 |
| Revenue YoY | -9.1% | -18.2% | -10.0% | -20.0% | ||||
| Profit YoY | – | – | – | – |
Standalone figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -0 | 1 | -1 | -1 | -1 | -1 |
| EPS (₹) | -0.12 | 0.20 | -0.28 | -0.22 | -0.30 | -0.43 |
| Revenue growth | – | – | – | -5.0% | -14.2% | |
| Profit growth | – | -236.9% | – | – | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | -14.2% |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 273 | 273 | 272 | 271 |
| Borrowings | – | 0 | 0 | 0 | 0 |
| Cash & equivalents | – | 0 | 0 | 0 | 0 |
| Total assets | – | 274 | 273 | 272 | 271 |
| Fixed assets | – | 2 | 2 | 2 | 2 |
| Capital work in progress | – | – | 0 | 0 | 0 |
| Inventory | – | 0 | 0 | 0 | 0 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | -5 | -1 | -1 | -6 | 0 |
| Cash from investing | 5 | 1 | 1 | 5 | -0 |
| Cash from financing | 0 | 0 | 0 | 0 | 0 |
| Capex | 0 | 0 | 0 | 0 | 0 |
| Free cash flow | -5 | -1 | -1 | -6 | 0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 0.2% | -0.3% | -0.3% | -0.4% |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 74.07% |
| FIIs | 2.32% |
| DIIs | 2.61% |
| Public (non-institutions) | 21.00% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 73.94% | 74.11% | 74.24% | 74.24% | 74.69% | 74.84% | 74.07% | 74.07% |
| Promoter group | % |
|---|---|
| Banwari Lal Mittal | 33.92% |
| Topview Enclaves LLP | 24.76% |
| Luv Kush Projects Limited | 11.96% |
| Ravi Kant Sharma | 2.35% |
| Sanjay Agarwal, Rahul Kumar Agrawal and Pratap Singh as Trustees of Microsec Vision Employees Trust | 1.28% |
| Bharati Sharma | 1.02% |
| Abha Mittal | 0.05% |
| Vidhi Mittal | 0.00% |
| Krishna Mittal | 0.00% |
| Saloni Mittal Beriwala | 0.00% |
| B L Mittal HUF (Karta Banwari Lal Mittal) | 0.00% |
| Sajjan Kumar Sharma | 0.00% |
| Kanta Devi Sharma | 0.00% |
| Mohit Sharma | 0.00% |
| Stuti Sharma | 0.00% |
| Public holders above 1% | % |
|---|---|
| Lekh Raj Juneja | 1.89% |
| Magnum Health And Safety Pvt Ltd | 1.33% |
| Airavat Capital Trust - Airavat Capital Trust II | 1.23% |
| Legends Global Opportunities (Singapore) Pte. Ltd. | 1.18% |
11,181 shareholders. Pledged: 0.00% of promoter shares.
Peers in Healthcare Service Provider
| Company | Market cap | P/E | P/B | ROE | ROA | Gross NPA | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| LALPATHLAB | ₹31,100 cr | 57.2x | 12.4x | 23.1% | 17.23% | – | +11.1% | 0.71% |
| VIJAYA | ₹14,362 cr | 76.6x | 15.0x | 21.4% | 12.44% | – | +21.0% | 0.14% |
| METROPOLIS | ₹10,989 cr | 54.5x | 7.3x | 14.2% | 9.43% | – | +12.8% | 0.19% |
| THYROCARE | ₹7,491 cr | 42.6x | 12.8x | 31.1% | 23.60% | – | +16.3% | 1.99% |
| NEPHROPLUS | ₹6,095 cr | 71.6x | 5.5x | 6.9% | 5.22% | – | – | – |
| SURAKSHA | ₹1,628 cr | 45.4x | 6.7x | 15.7% | 7.99% | – | – | – |
| KRSNAA | ₹1,617 cr | 16.6x | 1.6x | 10.5% | 5.34% | – | +16.6% | 0.55% |
| 3BBLACKBIO | ₹1,193 cr | 21.2x | 3.7x | 18.7% | 14.69% | – | +127.8% | 0.29% |
| HEALTHX | ₹857 cr | – | 3.2x | -0.5% | -0.50% | – | – | – |
| ONEGLOBAL | ₹773 cr | 10.5x | 5.5x | 69.4% | 28.96% | – | +201.8% | – |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2024-09-23 | Other | Annual General Meeting |
| 2023-09-22 | Other | Annual General Meeting |
| 2022-09-21 | Other | Annual General Meeting |
| 2021-09-20 | Other | Annual General Meeting |
| 2020-09-03 | Other | Annual General Meeting |
| 2019-09-20 | Other | Annual General Meeting |
| 2018-08-03 | Other | Annual General Meeting |
| 2017-07-28 | Other | Annual General Meeting |
| 2016-09-16 | Other | Annual General Meeting |
| 2015-09-16 | Other | Annual General Meeting |
| 2014-08-04 | Other | Annual General Meeting |
| 2013-08-02 | Other | Annual General Meeting |
| 2012-07-23 | Dividend | Annual General Meeting / Dividend Rs 1.00 Per Share |
| 2011-07-25 | Dividend | Annual General Meeting And Dividend Re.1/- Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Annual report FY22
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Sale of traded goods (medicines and OTC products): Wholesale trading of pharmaceutical products and OTC products
| Sector | Healthcare |
| Industry | Healthcare Service Provider |
| Sub-industry | Healthcare Service Provider |
| Symbol | HEALTHX |
| BSE code | 533259 |
| ISIN | INE019J01013 |
| Face value | ₹10.0 |
| Incorporated | 1989-06-06 |
| Website | www.healthxplatform.com |
| Plants (India / abroad) | 0 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.